SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-21-152020
Filing Date
2021-05-06
Accepted
2021-05-05 18:23:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d130717d424b3.htm 424B3 133083
2 GRAPHIC g130717g48i09.jpg GRAPHIC 44814
  Complete submission text file 0001193125-21-152020.txt   195992
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-255201 | Film No.: 21895015
SIC: 2834 Pharmaceutical Preparations